A woman who struggled with blocked airways for years and was left with a hole in her nose from decongestant spray says she ...

LIBERTY-AFRS-AIMS met its primary endpoint with a 50% reduction in CT sinus opacification at week 52 versus 10% with placebo (P<.0001).

NEW YORK, NY / ACCESS Newswire / February 22, 2026 / Jupiter, Florida, is an active community with lots of outdoor festivals and a multi-generational focus on health and wellness. Whether you are a ...

Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitisApproval in adults and ...

UC Davis Health has achieved a medical first that brings new hope to congenital heart patients born with a single ...

Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and ...

Chronic rhinosinusitis is a condition that causes inflammation of the sinuses and requires surgery after initial medical ...

Dr. Anita Louise Jackson, a Raleigh-area ear, nose and throat specialist once known for offering in-office sinus procedures, ...

People with allergic fungal rhinosinusitis taking Dupixent (dupilumab) saw significant improvement in congestion and sinus ...

These trends are remarkably consistent,” Dr. Dr. Anthony Brissett, a board certified facial plastic surgeon and president of ...

As February closes out American Heart Month, patients and doctors gathered at Ascension St. Vincent’s Riverside for a heart ...